{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:18Z","timestamp":1793813838477,"version":"4.6.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10096-016-2605-0","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T08:45:55Z","timestamp":1455266755000},"page":"723-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections"],"prefix":"10.1007","volume":"35","author":[{"given":"A.","family":"Sauerbrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"2605_CR1","first-page":"193","volume-title":"Virus taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses","author":"A Davison","year":"2005","unstructured":"Davison A, Eberle R, Hayward GS, McGeoch DJ, Minson AC, Pellett PE et al (2005) Herpesviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (eds) Virus taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, pp 193\u2013212"},{"key":"2605_CR2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/vir.0.017814-0","volume":"91","author":"J Breuer","year":"2010","unstructured":"Breuer J, Grose C, Norberg P, Tipples G, Schmid DS (2010) A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24\u201325 July 2008. J Gen Virol 91:821\u2013828","journal-title":"J Gen Virol"},{"key":"2605_CR3","first-page":"714","volume":"37","author":"MR Lokeshwar","year":"2000","unstructured":"Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J et al (2000) Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 37:714\u2013719","journal-title":"Indian Pediatr"},{"key":"2605_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(01)00276-6","volume":"20","author":"P Wutzler","year":"2001","unstructured":"Wutzler P, F\u00e4rber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121\u2013124","journal-title":"Vaccine"},{"key":"2605_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2010.08.014","volume":"11","author":"J Schmidt-Chanasit","year":"2011","unstructured":"Schmidt-Chanasit J, Sauerbrei A (2011) Evolution and world-wide distribution of varicella-zoster virus clades. Infect Genet Evol 11:1\u201310","journal-title":"Infect Genet Evol"},{"key":"2605_CR6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E (2015) Incidence of herpes zoster and its complications in Germany, 2005\u20132009. J Infect 70:178\u2013186","journal-title":"J Infect"},{"key":"2605_CR7","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1086\/514147","volume":"176","author":"AA Gershon","year":"1997","unstructured":"Gershon AA, Mervish N, LaRussa P, Steinberg S, Lo SH, Hodes D et al (1997) Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J Infect 176:1496\u20131500","journal-title":"J Infect"},{"key":"2605_CR8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1073\/pnas.93.5.2122","volume":"93","author":"R Mahalingam","year":"1996","unstructured":"Mahalingam R, Wellish M, Cohrs R, Debrus S, Piette J, Rentier B et al (1996) Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A 93:2122\u20132124","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2605_CR9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/vir.0.000128","volume":"96","author":"PG Kennedy","year":"2015","unstructured":"Kennedy PG, Rovnak J, Badani H, Cohrs RJ (2015) A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol 96:1581\u20131602","journal-title":"J Gen Virol"},{"key":"2605_CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0065-3527(08)60074-3","volume":"46","author":"AM Arvin","year":"1996","unstructured":"Arvin AM, Moffat JF, Redman R (1996) Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv Virus Res 46:263\u2013309","journal-title":"Adv Virus Res"},{"key":"2605_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-2008-1068845","volume":"110","author":"KE Schneweis","year":"1985","unstructured":"Schneweis KE, Krentler C, Wolff MH (1985) Durchseuchung mit dem Varicella-Zoster-Virus und serologische Feststellung der Erstimmunit\u00e4t. Dtsch Med Wochenschr 110:453\u2013457","journal-title":"Dtsch Med Wochenschr"},{"key":"2605_CR12","first-page":"44","volume-title":"Varicella-Zoster-Virus-Infektionen: Aktuelle Prophylaxe und Therapie","author":"A Sauerbrei","year":"2004","unstructured":"Sauerbrei A, Wutzler P (2004) Varicella-Zoster-Virus-Infektionen: Aktuelle Prophylaxe und Therapie, 1st edn. Uni-Med, Bremen, pp 44\u201353","edition":"1"},{"key":"2605_CR13","first-page":"567","volume":"105","author":"P Wutzler","year":"2008","unstructured":"Wutzler P, Knuf M, Liese J (2008) Varicella: efficacy of two-dose vaccination in childhood. Dtsch Arztebl Int 105:567\u2013572","journal-title":"Dtsch Arztebl Int"},{"key":"2605_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4615-4743-3_16","volume":"458","author":"AM Arvin","year":"1999","unstructured":"Arvin AM (1999) Management of varicella-zoster virus infections in children. Adv Exp Med Biol 458:167\u2013174","journal-title":"Adv Exp Med Biol"},{"key":"2605_CR15","first-page":"51","volume-title":"Congenital and other related infectious diseases of the newborn. Perspectives in Medical Virology","author":"A Sauerbrei","year":"2007","unstructured":"Sauerbrei A (2007) Varicella-zoster virus infections during pregnancy. In: Mushahwar K (ed) Congenital and other related infectious diseases of the newborn. Perspectives in Medical Virology, vol 13. Elsevier, Amsterdam, pp 51\u201373"},{"key":"2605_CR16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/rmv.502","volume":"16","author":"M Quinlivan","year":"2006","unstructured":"Quinlivan M, Breuer J (2006) Molecular studies of Varicella zoster virus. Rev Med Virol 16:225\u2013250","journal-title":"Rev Med Virol"},{"key":"2605_CR17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp048320","volume":"352","author":"M V\u00e1zquez","year":"2005","unstructured":"V\u00e1zquez M, Shapiro ED (2005) Varicella vaccine and infection with varicella-zoster virus. N Engl J Med 352:439\u2013440","journal-title":"N Engl J Med"},{"key":"2605_CR18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","volume":"14","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, K\u00f6ster I, Reinhold T, Siedler A, Krause G, Icks A et al (2013) Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ 14:1015\u20131026","journal-title":"Eur J Health Econ"},{"key":"2605_CR19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00103-013-1789-z","volume":"56","author":"A Siedler","year":"2013","unstructured":"Siedler A, Hecht J, Rieck T, Tolksdorf K, Hengel H (2013) Die Varizellenimpfung in Deutschland. Eine Zwischenbilanz mit Blick auf die Masern-Mumps-R\u00f6teln (MMR-)Impfung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:1313\u20131320","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2605_CR20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-2008-1047587","volume":"122","author":"G Gross","year":"1997","unstructured":"Gross G (1997) Zoster\u2014Manifestationsformen an der Haut, Komplikationen und Therapie. Dtsch Med Wochenschr 122:132\u2013139","journal-title":"Dtsch Med Wochenschr"},{"key":"2605_CR21","first-page":"A1129","volume":"94","author":"P Wutzler","year":"1997","unstructured":"Wutzler P, Meister W (1997) Herpes zoster\u2014Symptomatologie, demographische Daten und prognostische Faktoren. Dtsch \u00c4rztebl 94:A1129\u2013A1133","journal-title":"Dtsch \u00c4rztebl"},{"key":"2605_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-662-43481-9_10","volume-title":"S2k-Leitlinie: Labordiagnostik schwangerschaftsrelevanter Virusinfektionen","author":"A Sauerbrei","year":"2014","unstructured":"Sauerbrei A (2014) Windpocken (Varizellen). In: S2k-Leitlinie: Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Springer, Berlin, Heidelberg, pp 95\u2013110"},{"key":"2605_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1386-6532(99)00042-6","volume":"14","author":"A Sauerbrei","year":"1999","unstructured":"Sauerbrei A, Eichhorn U, Schacke M, Wutzler P (1999) Laboratory diagnosis of herpes zoster. J Clin Virol 14:31\u201336","journal-title":"J Clin Virol"},{"issue":"Suppl 1","key":"2605_CR24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S1386-6532(02)00033-1","volume":"25","author":"A Sauerbrei","year":"2002","unstructured":"Sauerbrei A, Wutzler P (2002) Laboratory diagnosis of central nervous system infections caused by herpesviruses. J Clin Virol 25(Suppl 1):S45\u2013S51","journal-title":"J Clin Virol"},{"key":"2605_CR25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1386-6532(03)00071-4","volume":"27","author":"A Sauerbrei","year":"2003","unstructured":"Sauerbrei A, Uebe B, Wutzler P (2003) Molecular diagnosis of zoster post varicella vaccination. J Clin Virol 27:190\u2013199","journal-title":"J Clin Virol"},{"key":"2605_CR26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00430-010-0178-6","volume":"200","author":"A Sauerbrei","year":"2011","unstructured":"Sauerbrei A, Stefanski J, Philipps A, Krumbholz A, Zell R, Wutzler P (2011) Monitoring prevalence of varicella-zoster virus clades in Germany. Med Microbiol Immunol 200:99\u2013107","journal-title":"Med Microbiol Immunol"},{"key":"2605_CR27","unstructured":"Sauerbrei A, Wutzler P (2004) Labordiagnostik der Varizellen. Kinder\u00e4rztl Prax, Sonderheft Impfen, pp 18\u201321"},{"key":"2605_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jviromet.2004.02.012","volume":"119","author":"A Sauerbrei","year":"2004","unstructured":"Sauerbrei A, F\u00e4rber I, Brandst\u00e4dt A, Schacke M, Wutzler P (2004) Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J Virol Methods 119:25\u201330","journal-title":"J Virol Methods"},{"key":"2605_CR29","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1128\/JCM.00719-06","volume":"44","author":"A Sauerbrei","year":"2006","unstructured":"Sauerbrei A, Wutzler P (2006) Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol 44:3094\u20133097","journal-title":"J Clin Microbiol"},{"key":"2605_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-4-33","volume":"4","author":"RH Kneitz","year":"2004","unstructured":"Kneitz RH, Schubert J, Tollmann F, Zens W, Hedman K, Weissbrich B (2004) A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect Dis 4:33","journal-title":"BMC Infect Dis"},{"key":"2605_CR31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/clinids\/21.5.1348","volume":"21","author":"AM Fillet","year":"1995","unstructured":"Fillet AM, Visse B, Caumes E, Dumont B, Gentilini M, Huraux JM (1995) Foscarnet-resistant multidermatomal zoster in a patient with AIDS. Clin Infect Dis 21:1348\u20131349","journal-title":"Clin Infect Dis"},{"key":"2605_CR32","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1086\/324503","volume":"33","author":"E Saint-L\u00e9ger","year":"2001","unstructured":"Saint-L\u00e9ger E, Caumes E, Breton G, Douard D, Saiag P, Huraux JM et al (2001) Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. Clin Infect Dis 33:2061\u20132067","journal-title":"Clin Infect Dis"},{"key":"2605_CR33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2011.04.005","volume":"90","author":"A Sauerbrei","year":"2011","unstructured":"Sauerbrei A, Taut J, Zell R, Wutzler P (2011) Resistance testing of clinical varicella-zoster virus strains. Antiviral Res 90:242\u2013247","journal-title":"Antiviral Res"},{"key":"2605_CR34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","volume":"55","author":"J Piret","year":"2011","unstructured":"Piret J, Boivin G (2011) Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55:459\u2013472","journal-title":"Antimicrob Agents Chemother"},{"key":"2605_CR35","first-page":"254","volume":"7","author":"HH Balfour Jr","year":"1994","unstructured":"Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A et al (1994) Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 7:254\u2013260","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2605_CR36","first-page":"151","volume":"24","author":"A Sauerbrei","year":"2014","unstructured":"Sauerbrei A (2014) Diagnostik und antivirale Therapie von Herpes-simplex-Virus-Infektionen. Der Mikrobiol 24:151\u2013158","journal-title":"Der Mikrobiol"},{"key":"2605_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-115-1-19","volume":"115","author":"S Safrin","year":"1991","unstructured":"Safrin S, Berger TG, Gilson I, Wolfe PR, Wofsy CB, Mills J et al (1991) Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med 115:19\u201321","journal-title":"Ann Intern Med"},{"key":"2605_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","volume":"26","author":"F Morfin","year":"2003","unstructured":"Morfin F, Thouvenot D (2003) Herpes simplex virus resistance to antiviral drugs. J Clin Virol 26:29\u201337","journal-title":"J Clin Virol"},{"key":"2605_CR39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM199108223250805","volume":"325","author":"S Safrin","year":"1991","unstructured":"Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al (1991) A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med 325:551\u2013555","journal-title":"N Engl J Med"},{"key":"2605_CR40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2014.03.015","volume":"107","author":"A Schubert","year":"2014","unstructured":"Schubert A, Gentner E, Bohn K, Schwarz M, Mertens T, Sauerbrei A (2014) Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes. Antiviral Res 107:16\u201322","journal-title":"Antiviral Res"},{"key":"2605_CR41","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.05115-14","volume":"59","author":"AK Brunnemann","year":"2015","unstructured":"Brunnemann AK, Bohn-Wippert K, Zell R, Henke A, Walther M, Braum O et al (2015) Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate. Antimicrob Agents Chemother 59:2726\u20132734","journal-title":"Antimicrob Agents Chemother"},{"key":"2605_CR42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/CVI.00645-13","volume":"21","author":"SH Oh","year":"2014","unstructured":"Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM et al (2014) Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol 21:762\u2013768","journal-title":"Clin Vaccine Immunol"},{"key":"2605_CR43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1201-9712(97)90075-8","volume":"1","author":"AA Gershon","year":"1997","unstructured":"Gershon AA (1997) Live attenuated varicella vaccine. Int J Infect Dis 1:130\u2013134","journal-title":"Int J Infect Dis"},{"key":"2605_CR44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","volume":"2","author":"M Takahashi","year":"1974","unstructured":"Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288\u20131290","journal-title":"Lancet"},{"key":"2605_CR45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.inf.0000219484.55858.a2","volume":"25","author":"A Arvin","year":"2006","unstructured":"Arvin A, Gershon A (2006) Control of varicella: why is a two-dose schedule necessary? Pediatr Infect Dis J 25:475\u2013476","journal-title":"Pediatr Infect Dis J"},{"key":"2605_CR46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1745-7599.2006.00163.x","volume":"18","author":"KE Luthy","year":"2006","unstructured":"Luthy KE, Tiedeman ME, Beckstrand RL, Mills DA (2006) Safety of live-virus vaccines for children with immune deficiency. J Am Acad Nurse Pract 18:494\u2013503","journal-title":"J Am Acad Nurse Pract"},{"key":"2605_CR47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12889-015-1861-8","volume":"15","author":"O Damm","year":"2015","unstructured":"Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O (2015) Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health 15:533","journal-title":"BMC Public Health"},{"key":"2605_CR48","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","volume":"32","author":"JG Liese","year":"2013","unstructured":"Liese JG, Cohen C, Rack A, Pirzer K, Eber S, Blum M et al (2013) The effectiveness of varicella vaccination in children in Germany: a case\u2013control study. Pediatr Infect Dis J 32:998\u20131004","journal-title":"Pediatr Infect Dis J"},{"key":"2605_CR49","first-page":"1","volume":"17","author":"AA Gershon","year":"2001","unstructured":"Gershon AA (2001) The current status of live attenuated varicella vaccine. Arch Virol Suppl 17:1\u20136","journal-title":"Arch Virol Suppl"},{"key":"2605_CR50","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1542\/peds.2011-0017","volume":"128","author":"SS Chaves","year":"2011","unstructured":"Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L et al (2011) Varicella in infants after implementation of the US varicella vaccination program. Pediatrics 128:1071\u20131077","journal-title":"Pediatrics"},{"key":"2605_CR51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","volume":"287","author":"JF Seward","year":"2002","unstructured":"Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX et al (2002) Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000. JAMA 287:606\u2013611","journal-title":"JAMA"},{"key":"2605_CR52","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/338959","volume":"34","author":"K Ampofo","year":"2002","unstructured":"Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A (2002) Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis 34:774\u2013779","journal-title":"Clin Infect Dis"},{"key":"2605_CR53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","volume":"23","author":"B Kuter","year":"2004","unstructured":"Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B et al (2004) Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23:132\u2013137","journal-title":"Pediatr Infect Dis J"},{"key":"2605_CR54","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","volume":"122","author":"M Marin","year":"2008","unstructured":"Marin M, Meissner HC, Seward JF (2008) Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122:e744\u2013e751","journal-title":"Pediatrics"},{"key":"2605_CR55","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1542\/peds.2004-1162","volume":"115","author":"M Marin","year":"2005","unstructured":"Marin M, Nguyen HQ, Keen J, Jumaan AO, Mellen PM, Hayes EB et al (2005) Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002\u20132003. Pediatrics 115:900\u2013905","journal-title":"Pediatrics"},{"key":"2605_CR56","first-page":"174","volume":"63","author":"AS Lopez","year":"2014","unstructured":"Lopez AS, Cardemil C, Pabst LJ, Cullen KA, Leung J, Bialek SR et al (2014) Two-dose varicella vaccination coverage among children aged 7 years\u2014six sentinel sites, United States, 2006\u20132012. MMWR Morb Mortal Wkly Rep 63:174\u2013177","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2605_CR57","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F (2011) Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination. Clin Infect Dis 52:332\u2013340","journal-title":"Clin Infect Dis"},{"key":"2605_CR58","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00112-014-3262-y","volume":"162","author":"A Sauerbrei","year":"2014","unstructured":"Sauerbrei A (2014) Herpes zoster im Kindes- und Jugendalter. Monatsschr Kinderheilkd 162:1135\u20131144","journal-title":"Monatsschr Kinderheilkd"},{"key":"2605_CR59","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","volume":"208","author":"S Weinmann","year":"2013","unstructured":"Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K et al (2013) Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009. J Infect Dis 208:1859\u20131868","journal-title":"J Infect Dis"},{"key":"2605_CR60","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00431-002-0981-1","volume":"161","author":"B Uebe","year":"2002","unstructured":"Uebe B, Sauerbrei A, Burdach S, Horneff G (2002) Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child. Eur J Pediatr 161:442\u2013444","journal-title":"Eur J Pediatr"},{"key":"2605_CR61","first-page":"235","volume":"30","author":"Robert Koch-Institut","year":"2004","unstructured":"Robert Koch-Institut (2004) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (Stand: Juli 2004). Epidemiol Bull 30:235\u2013250","journal-title":"Epidemiol Bull"},{"key":"2605_CR62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-13-303","volume":"13","author":"A Streng","year":"2013","unstructured":"Streng A, Grote V, Carr D, Hagemann C, Liese JG (2013) Varicella routine vaccination and the effects on varicella epidemiology\u2014results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006\u20132011. BMC Infect Dis 13:303","journal-title":"BMC Infect Dis"},{"key":"2605_CR63","first-page":"279","volume":"30","author":"Robert Koch-Institut","year":"2009","unstructured":"Robert Koch-Institut (2009) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (Stand: Juli 2009). Epidemiol Bull 30:279\u2013298","journal-title":"Epidemiol Bull"},{"key":"2605_CR64","first-page":"352","volume":"38","author":"Robert Koch-Institut","year":"2011","unstructured":"Robert Koch-Institut (2011) Zur Kombinationsimpfung gegen Masern, Mumps, R\u00f6teln und Varizellen (MMRV). Epidemiol Bull 38:352\u2013353","journal-title":"Epidemiol Bull"},{"key":"2605_CR65","first-page":"327","volume":"34","author":"Robert Koch-Institut","year":"2015","unstructured":"Robert Koch-Institut (2015) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (Stand: August 2015). Epidemiol Bull 34:327\u2013362","journal-title":"Epidemiol Bull"},{"key":"2605_CR66","first-page":"70","volume-title":"Varicella-Zoster-Virus-Infektionen: Aktuelle Prophylaxe und Therapie","author":"A Sauerbrei","year":"2007","unstructured":"Sauerbrei A, Wutzler P (2007) Varicella-Zoster-Virus-Infektionen: Aktuelle Prophylaxe und Therapie, 2nd edn. Uni-Med, Bremen, pp 70\u201387","edition":"2"},{"key":"2605_CR67","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","volume":"197","author":"SA Galea","year":"2008","unstructured":"Galea SA, Sweet A, Beninger P, Steinberg SP, LaRussa PS, Gershon AA et al (2008) The safety profile of varicella vaccine: a 10-year review. J Infect Dis 197:S165\u2013S169","journal-title":"J Infect Dis"},{"key":"2605_CR68","first-page":"273","volume":"31","author":"Robert Koch-Institut","year":"2005","unstructured":"Robert Koch-Institut (2005) Neuerungen in den aktuellen Impfempfehlungen der STIKO. Epidemiol Bull 31:273\u2013276","journal-title":"Epidemiol Bull"},{"key":"2605_CR69","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1503\/cmaj.110055","volume":"183","author":"A Sauerbrei","year":"2011","unstructured":"Sauerbrei A (2011) Preventing congenital varicella syndrome with immunization. CMAJ 183:E169\u2013E170","journal-title":"CMAJ"},{"key":"2605_CR70","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMp058091","volume":"352","author":"A Arvin","year":"2005","unstructured":"Arvin A (2005) Aging, immunity, and the varicella-zoster virus. N Engl J Med 352:2266\u20132267","journal-title":"N Engl J Med"},{"key":"2605_CR71","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271\u20132284","journal-title":"N Engl J Med"},{"key":"2605_CR72","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4161\/hv.23412","volume":"9","author":"T Vesikari","year":"2013","unstructured":"Vesikari T, Hardt R, R\u00fcmke HC, Icardi G, Montero J, Thomas S et al (2013) Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax\u00ae) in individuals aged \u226570 years: a randomized study of a single dose vs. two different two-dose schedules. Hum Vaccin Immunother 9:858\u2013564","journal-title":"Hum Vaccin Immunother"},{"key":"2605_CR73","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","volume":"206","author":"I Leroux-Roels","year":"2012","unstructured":"Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapeli\u00e8re P, Vassilev V, Ledent E et al (2012) A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults. J Infect Dis 206:1280\u20131290","journal-title":"J Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2605-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2605-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2605-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:14:34Z","timestamp":1692206074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2605-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2605"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2605-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}